1. Home
  2. TNC vs IMCR Comparison

TNC vs IMCR Comparison

Compare TNC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tennant Company

TNC

Tennant Company

HOLD

Current Price

$75.39

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$35.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TNC
IMCR
Founded
1870
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TNC
IMCR
Price
$75.39
$35.52
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$113.50
$67.00
AVG Volume (30 Days)
124.3K
336.8K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
1.62%
N/A
EPS Growth
N/A
N/A
EPS
2.91
N/A
Revenue
$1,240,800,000.00
$379,590,000.00
Revenue This Year
N/A
$32.31
Revenue Next Year
$5.63
$10.50
P/E Ratio
$26.27
N/A
Revenue Growth
N/A
28.11
52 Week Low
$67.32
$23.15
52 Week High
$90.44
$40.72

Technical Indicators

Market Signals
Indicator
TNC
IMCR
Relative Strength Index (RSI) 50.39 46.92
Support Level $72.73 $35.35
Resistance Level $77.82 $38.40
Average True Range (ATR) 1.71 1.91
MACD 0.45 -0.41
Stochastic Oscillator 54.15 13.62

Price Performance

Historical Comparison
TNC
IMCR

About TNC Tennant Company

Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: